RespireRx Pharmaceuticals Inc (RSPI): Years ago, early stage efficacy did offe...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	17
Posts	1798
Boards Moderated	0
Alias Born	10/11/2007

food4thought

Re: Big Tom7 post# 42606

Tuesday, 10/27/2020 8:09:04 PM

Tuesday, October 27, 2020 8:09:04 PM

Years ago, early stage efficacy did offer hope for a variety of modalities, but it appears ampakines will never make it to market. I lost a small fortune in this company. I could be wrong but can’t see how the pipeline survives. For the sake of other investors here, I hope I’m wrong. GLTY.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent RSPI News

Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2024 12:45:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 12:30:23 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 08:01:32 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 01:03:20 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 01:30:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 01:45:38 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 01:45:18 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/17/2023 09:06:03 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 09:05:14 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 01:00:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 12:45:26 PM